Variant report

Variant	esv3338870
Chromosome Location	chr5:74159996-74164294
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:74162220-74162288	HepG2	liver:	n/a	n/a
2	ARID3A	chr5:74162526-74163038	HepG2	liver:	n/a	n/a
3	ARID3A	chr5:74160742-74161053	HepG2	liver:	n/a	n/a
4	BACH1	chr5:74162622-74163006	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCL3	chr5:74162403-74162827	A549	lung:	n/a	chr5:74162427-74162440 chr5:74162711-74162720
6	BHLHE40	chr5:74162233-74163047	HepG2	liver:	n/a	chr5:74162352-74162368
7	CEBPB	chr5:74160717-74161164	MCF-7	breast:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
8	CEBPB	chr5:74160706-74161130	HepG2	liver:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
9	CEBPB	chr5:74160744-74161091	A549	lung:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
10	CEBPB	chr5:74160803-74161112	ECC-1	luminal epithelium:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
11	CEBPB	chr5:74160756-74161001	HepG2	liver:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
12	CEBPB	chr5:74160786-74161070	IMR90	lung:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
13	CEBPB	chr5:74160621-74161159	MCF-7	breast:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
14	CEBPB	chr5:74162595-74162943	HepG2	liver:	n/a	n/a
15	CEBPB	chr5:74160652-74161123	HepG2	liver:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
16	CEBPB	chr5:74160819-74161038	K562	blood:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
17	CEBPB	chr5:74160738-74161102	H1-hESC	embryonic stem cell:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
18	CEBPB	chr5:74160726-74161091	HepG2	liver:	n/a	chr5:74160930-74160941 chr5:74160890-74160901
19	CEBPD	chr5:74160773-74161056	HepG2	liver:	n/a	n/a
20	CEBPD	chr5:74162496-74162853	HepG2	liver:	n/a	n/a
21	CEBPD	chr5:74161985-74162435	HepG2	liver:	n/a	n/a
22	CHD1	chr5:74160489-74163268	H1-hESC	embryonic stem cell:	n/a	chr5:74162137-74162147 chr5:74162977-74162984
23	CHD1	chr5:74161569-74161639	GM12878	blood:	n/a	n/a
24	CHD2	chr5:74161222-74161392	HepG2	liver:	n/a	n/a
25	CHD2	chr5:74161698-74161898	H1-hESC	embryonic stem cell:	n/a	n/a
26	CHD2	chr5:74162031-74162153	HepG2	liver:	n/a	chr5:74162137-74162147
27	CREB1	chr5:74161764-74162679	A549	lung:	n/a	n/a
28	CREB1	chr5:74161946-74162996	H1-hESC	embryonic stem cell:	n/a	n/a
29	CREB1	chr5:74160647-74163073	HepG2	liver:	n/a	n/a
30	CREB1	chr5:74161961-74162669	H1-hESC	embryonic stem cell:	n/a	n/a
31	CTBP2	chr5:74161126-74162967	H1-hESC	embryonic stem cell:	n/a	n/a
32	CTCF	chr5:74161640-74161790	GM12870	blood:	n/a	chr5:74161750-74161760 chr5:74161748-74161761
33	CTCF	chr5:74161625-74161816	GM19239	blood:	n/a	chr5:74161750-74161760 chr5:74161788-74161801 chr5:74161748-74161761
34	CTCF	chr5:74161680-74161830	SK-N-SH_RA	brain:	n/a	chr5:74161750-74161760 chr5:74161788-74161801 chr5:74161748-74161761
35	CTCF	chr5:74161620-74161770	GM12866	blood:	n/a	chr5:74161750-74161760 chr5:74161748-74161761
36	CTCF	chr5:74162033-74162300	MCF-7	breast:	n/a	n/a
37	CTCF	chr5:74162100-74162250	SAEC	small airway:	n/a	n/a
38	CTCF	chr5:74161729-74161772	GM12878	blood:	n/a	chr5:74161750-74161760 chr5:74161748-74161761
39	CTCF	chr5:74162124-74162295	A549	lung:	n/a	n/a
40	CTCF	chr5:74161696-74161835	GM13977	blood:	n/a	chr5:74161750-74161760 chr5:74161788-74161801 chr5:74161748-74161761
41	CTCF	chr5:74161604-74161936	MCF-7	breast:	n/a	chr5:74161750-74161760 chr5:74161851-74161864 chr5:74161788-74161801 chr5:74161748-74161761
42	CTCF	chr5:74162109-74162275	NHEK	skin:	n/a	n/a
43	CTCF	chr5:74162168-74162253	H1-hESC	embryonic stem cell:	n/a	n/a
44	CTCF	chr5:74161693-74161823	MCF-7	breast:	n/a	chr5:74161750-74161760 chr5:74161788-74161801 chr5:74161748-74161761
45	CTCF	chr5:74161680-74161830	WERI-Rb-1	eye:	n/a	chr5:74161750-74161760 chr5:74161788-74161801 chr5:74161748-74161761
46	CTCF	chr5:74161640-74161790	GM12871	blood:	n/a	chr5:74161750-74161760 chr5:74161748-74161761
47	CTCF	chr5:74162167-74162249	Gliobla	brain:	n/a	n/a
48	CTCF	chr5:74162026-74162285	MCF-7	breast:	n/a	n/a
49	CTCF	chr5:74161688-74161785	GM12892	blood:	n/a	chr5:74161750-74161760 chr5:74161748-74161761
50	CTCF	chr5:74161920-74162070	HEK293	kidney:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:74162880-74162930	PANC-1	pancreas:	n/a
2	chr5:74162771-74162821	HPAEpiC	pulmonary alveolar:	n/a
3	chr5:74162880-74162930	PANC-1	pancreas:	n/a
4	chr5:74162771-74162821	HPAEpiC	pulmonary alveolar:	n/a
5	chr5:74162621-74162671	SKMC	muscle:	n/a
6	chr5:74161187-74161237	K562	blood:	n/a
7	chr5:74162771-74162821	LNCaP	prostate:	n/a
8	chr5:74161187-74161237	LNCaP	prostate:	n/a
9	chr5:74162621-74162671	HCT-116	colon:	n/a
10	chr5:74163723-74163773	SK-N-SH_RA	brain:	n/a
11	chr5:74162623-74162673	GM12892	blood:	n/a
12	chr5:74162771-74162821	NHDF-neo	bronchial:	n/a
13	chr5:74162880-74162930	ovcar-3	ovarian:	n/a
14	chr5:74162458-74162508	SK-N-MC	brain:	n/a
15	chr5:74162924-74162974	HCM	heart:	n/a
16	chr5:74161231-74161281	MCF10A-Er-Src	breast:	n/a
17	chr5:74162851-74162901	K562	blood:	n/a
18	chr5:74162621-74162671	HCF	heart:	n/a
19	chr5:74161231-74161281	NT2-D1	testis:	n/a
20	chr5:74161231-74161281	H1-hESC	embryonic stem cell:	embryo
21	chr5:74162623-74162673	SK-N-SH	brain:	n/a
22	chr5:74161187-74161237	NT2-D1	testis:	n/a
23	chr5:74162602-74162652	H1-hESC	embryonic stem cell:	embryo
24	chr5:74162771-74162821	HCM	heart:	n/a
25	chr5:74161231-74161281	ProgFib	skin:	n/a
26	chr5:74161187-74161237	HEEpiC	esophagus:	n/a
27	chr5:74161556-74161606	MCF10A-Er-Src	breast:	n/a
28	chr5:74162809-74162859	HCM	heart:	n/a
29	chr5:74162458-74162508	U87	brain:	n/a
30	chr5:74161556-74161606	ProgFib	skin:	n/a
31	chr5:74162458-74162508	RPTEC	kidney:	n/a
32	chr5:74162602-74162652	HCF	heart:	n/a
33	chr5:74162771-74162821	A549	lung:	n/a
34	chr5:74163723-74163773	GM06990	blood:	n/a
35	chr5:74161187-74161237	AG04450	lung:	fetal
36	chr5:74162851-74162901	MCF-7	breast:	n/a
37	chr5:74161187-74161237	ovcar-3	ovarian:	n/a
38	chr5:74161187-74161237	SK-N-SH	brain:	n/a
39	chr5:74161187-74161237	NH-A	brain:	n/a
40	chr5:74161231-74161281	PrEC	prostate:	n/a
41	chr5:74162223-74162273	GM12892	blood:	n/a
42	chr5:74162623-74162673	HMEC	breast:	n/a
43	chr5:74162924-74162974	HCT-116	colon:	n/a
44	chr5:74162924-74162974	SKMC	muscle:	n/a
45	chr5:74162621-74162671	HepG2	liver:	n/a
46	chr5:74161187-74161237	SKMC	muscle:	n/a
47	chr5:74162602-74162652	GM19239	blood:	n/a
48	chr5:74162809-74162859	HCT-116	colon:	n/a
49	chr5:74162880-74162930	GM12878	blood:	n/a
50	chr5:74161187-74161237	AoSMC	blood vessel:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:74136109..74138660-chr5:74163363..74165168,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NSA2-6	chr5:74161718-74163679	ENSG00000271714.1

Variant related genes	Relation type
ENSG00000271714	TF binding region
FAM169A	TF binding region
ENSG00000271714	CpG island
FAM169A	CpG island

Extended variants
information (count: 130 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:130 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs547053186	chr5:74160014-74160015	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs190155249	chr5:74160021-74160022	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs535796826	chr5:74160022-74160023	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs374328617	chr5:74160024-74160025	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs183252248	chr5:74160050-74160051	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs111782496	chr5:74160119-74160120	Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs575759978	chr5:74160224-74160225	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs574447604	chr5:74160246-74160247	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs554941355	chr5:74160247-74160248	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs114607128	chr5:74160322-74160323	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs542181694	chr5:74160346-74160347	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs188666235	chr5:74160357-74160358	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs78709455	chr5:74160435-74160436	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs16872364	chr5:74160455-74160456	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs191769013	chr5:74160507-74160508	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs530613670	chr5:74160603-74160604	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs550782211	chr5:74160608-74160609	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs17738674	chr5:74160654-74160655	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs184013969	chr5:74160695-74160696	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs552812519	chr5:74160748-74160749	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs188026766	chr5:74160752-74160753	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs566875340	chr5:74160769-74160770	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs142100898	chr5:74160798-74160799	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs191339686	chr5:74160813-74160814	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs144951266	chr5:74160814-74160815	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs563767707	chr5:74160837-74160838	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs552695240	chr5:74160885-74160886	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs569381747	chr5:74161001-74161002	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs142025901	chr5:74161076-74161077	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs555158780	chr5:74161182-74161183	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs568631566	chr5:74161204-74161205	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs183854084	chr5:74161292-74161293	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs375879218	chr5:74161368-74161369	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs533939715	chr5:74161502-74161503	Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs552507713	chr5:74161508-74161509	Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs572494468	chr5:74161560-74161561	Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
37	rs544649396	chr5:74161615-74161616	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs538671392	chr5:74161631-74161632	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs558349301	chr5:74161647-74161648	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs575333469	chr5:74161650-74161651	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs113153511	chr5:74161677-74161678	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs544044849	chr5:74161697-74161698	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs369887417	chr5:74161776-74161777	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
44	rs529969278	chr5:74161797-74161798	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
45	rs540543794	chr5:74161798-74161799	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs560475940	chr5:74161817-74161818	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs532549698	chr5:74161818-74161819	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs552573951	chr5:74161894-74161895	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs112922856	chr5:74161972-74161973	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs556521918	chr5:74162014-74162015	Active TSS Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Prostate cancer	21965145	CNVD
Spinal muscular atrophy	21762474	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Bladder cancer	21909424	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Ovarian cancer	21720365	CNVD
Spinal muscular atrophy	15981080	CNVD
Spinal muscular atrophy	18839960	CNVD
Spinal muscular atrophy	19716110	CNVD
Glioblastoma multiforme	22286061	CNVD
craniofacial dysmorphism	21918468	CNVD
Multiple myeloma	16616336	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	17133270	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian cancer	22355333	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelofibrosis	22110671	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:501 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:74140600-74160000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr5:74147400-74161000	Weak transcription	Primary T cells from cord blood	blood
3	chr5:74148200-74161200	Weak transcription	Right Atrium	heart
4	chr5:74148800-74160000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr5:74148800-74160600	Weak transcription	A549	lung
6	chr5:74148800-74160800	Weak transcription	Primary hematopoietic stem cells	blood
7	chr5:74149400-74160600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
8	chr5:74149400-74160800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
9	chr5:74157200-74161000	Enhancers	Primary T helper cells PMA-I stimulated	--
10	chr5:74157800-74160000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
11	chr5:74157800-74160000	Enhancers	Brain Hippocampus Middle	brain
12	chr5:74157800-74160800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr5:74158000-74160000	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
14	chr5:74158000-74160200	Enhancers	Brain Inferior Temporal Lobe	brain
15	chr5:74158200-74160200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr5:74158400-74160200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
17	chr5:74158600-74160400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
18	chr5:74158600-74161000	Weak transcription	Cortex derived primary cultured neurospheres	brain
19	chr5:74158600-74163000	Active TSS	H1 Cell Line	embryonic stem cell
20	chr5:74158800-74163800	Active TSS	ES-I3 Cell Line	embryonic stem cell
21	chr5:74159000-74160000	Flanking Active TSS	HepG2	liver
22	chr5:74159000-74160400	Weak transcription	Brain Angular Gyrus	brain
23	chr5:74159000-74160400	Enhancers	Pancreatic Islets	Pancreatic Islet
24	chr5:74159000-74162800	Active TSS	HUES6 Cell Line	embryonic stem cell
25	chr5:74159200-74160000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
26	chr5:74159200-74160000	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
27	chr5:74159200-74160000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
28	chr5:74159200-74160400	Weak transcription	Brain Cingulate Gyrus	brain
29	chr5:74159400-74160200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
30	chr5:74159400-74160600	Enhancers	Dnd41	blood
31	chr5:74159400-74160600	Enhancers	HMEC	breast
32	chr5:74159400-74160800	Enhancers	Brain Substantia Nigra	brain
33	chr5:74159400-74161000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
34	chr5:74159400-74161000	Flanking Active TSS	NHEK	skin
35	chr5:74159400-74163000	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr5:74159400-74163000	Active TSS	H9 Cell Line	embryonic stem cell
37	chr5:74159400-74163800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
38	chr5:74159600-74160600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
39	chr5:74159600-74160600	Weak transcription	Brain Anterior Caudate	brain
40	chr5:74159600-74160800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
41	chr5:74159600-74161000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
42	chr5:74159600-74162800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr5:74159800-74160600	Weak transcription	Fetal Brain Male	brain
44	chr5:74159800-74160800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
45	chr5:74159800-74160800	Enhancers	Primary T helper cells fromperipheralblood	blood
46	chr5:74159800-74163000	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
47	chr5:74160000-74160200	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr5:74160000-74160200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
49	chr5:74160000-74160400	Active TSS	HUES48 Cell Line	embryonic stem cell
50	chr5:74160000-74160400	Active TSS	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links